/
Why are new drugs and cheaper, more user friendly regimes needed? Why are new drugs and cheaper, more user friendly regimes needed?

Why are new drugs and cheaper, more user friendly regimes needed? - PowerPoint Presentation

dandy
dandy . @dandy
Follow
27 views
Uploaded On 2024-02-09

Why are new drugs and cheaper, more user friendly regimes needed? - PPT Presentation

Tuberculosis Drug Resistance and the History of Modern Medicine Salmaan Keshavjee and Paul Farmer N Engl J Med 2012 Sep 6367109316 Tuberculosis whether caused by drugsusceptible or drugresistant strains rarely made even medical headlines in part because its importance as a caus ID: 1046092

2012 drug care mdr drug 2012 mdr care farmer www tuberculosis resistance health resistant keshavjee paul diagnosed cost 100

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Why are new drugs and cheaper, more user..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Why are new drugs and cheaper, more user friendly regimes needed?

2. * Tuberculosis, Drug Resistance, and the History of Modern Medicine. Salmaan Keshavjee and Paul Farmer. N Engl J Med. 2012 Sep 6;367(10):931-6."Tuberculosis, whether caused by drug-susceptible or drug-resistant strains, rarely made even medical headlines, in part because its importance as a cause of death continued to decline in areas in which headlines are written.”Keshavjee and Farmer, NEJM, 2012*And what TB crisis?

3. *Tuberculosis, Drug Resistance, and the History of Modern Medicine. Salmaan Keshavjee and Paul Farmer. N Engl J Med. 2012 Sep 6;367(10):931-6.Cost-ineffective?“…selective primary health care and ‘cost-effectiveness’ have shaped an anemic response to the ongoing global pandemic.”*

4. Slide courtesy: Prof Keertan Dheda

5. Financing the scale-up of MDR-TB prevention and Treatment. Katherine Floyd, Stop TB, WHO. Ministerial meeting. Beijing, China, 2009http://www.who.int/tb_beijingmeeting/media/press_pack/presentations/day2_presentation3.pdfSA : MDR-TB already >55% of TB budget!

6. The perception among the majority is that we are not at risk of being infected by TB. This assumption is deeply flawed.Dr Madhukar Pai, India Tribune, 29 October 2012http://www.tribuneindia.com/2012/20121029/edit.htm#6The RNTCP needs to think beyond treatment of drug-resistant TB, and focus on preventing a major epidemic. In the case of drug-resistant TB, an ounce of prevention is definitely better than a pound of cure

7. Care for the carer±1/100: number of South Africans diagnosed with TB last year (WHO, 2012). 3x: increased rate of TB among Health Care Workers globally (Baussano, 2011).6.3%: confirmed drug-resistance among occupational TB cases at Tygerberg Hospital (Data: 2008-2011).5.56x higher incidence rate of MDR- and XDR (O’Donnell, 2010)Means 3/100 HCW’s could be diagnosed with TB every yearAt least 1/16 could have MDR-TB or worse

8. Lucky and thankful…Dalene got her life back, she can still hear, and can even practice as a clinician again…what next?TB PROOF

9.

10. Start at the beginning:

11. 2nd Year Medical Students

12. Anyone can get TBhttp://www.health24.com/tools/Slideshows/1891-4704-4775,61850.aspNobel peace prize TB survivors“UBUNTU” – I am because we areWe are all in this together!

13. HOPE: Life after TBSA record: 114m in one breath!

14. Thank you!Physicians:Paul Willcox Andreas DiaconSimon SchaafTony BiebuyckJantjie TaljaardKeertan DhedaPharmacologyGary MaartensElsimé Kift Jeannine Du Bois SupportiveJustus Apffelstaedt - SurgeryMou Manie - RheumatologyAnton Doubell - CardiologyMark Abelson – CardiologyProf Loock – Ear, nose and throatRadiologySucari VlokArthur Maydall Jan Lotz Occupational Health/TBHJack MeintjiesSr SamuelsSr ArendseMatodzi Mukosi - superElmarie MalekMariana KrugerSAMA - Daniel MadibaCBTBR/Genetics:Gerhard WalzlBelinda KrielDaleen KrielRob WarrenTommie VictorSoraya Bardien-KrugerLizma StreicherTibotec/Janssen:David McNeeleyGilles van BaarNHLS Mariza HoffmanHaematology and Microbiology TechnologistsAudiology:Rene VisagieSharon PitheyTygerberg AudiologistsCAPRISANesri PadayatchiKogieleum NaidooTB PROOFAngela DramowskiBart WillemsHeena NarotamHelene-Mari van der WesthuizenKoot KotzeTreatment Action Group

15. “The momentum to break this disease is in real danger. We are now at a crossroads between TB elimination within our lifetime, and millions more TB deaths.” Dr Mario Raviglione; Director of the WHO Stop TB Department; 17 October 2012Questions?